Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Yousef Odeh

Thoracic Surgery (Cardiothoracic Vascular Surgery) Los Angeles, CA Medical Doctor

NPI 1912930629 CMS profile 930333

10833 Le Conte Ave, Ste 101, Los Angeles, CA 90095

Open in the dashboard

General payments

$25,412

302 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Yousef Odeh of Los Angeles, CA is reported in the CMS Open Payments database as having received $25,412 across 302 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 83rd percentile of Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,692 45
2024 General $3,333 61
2023 General $2,234 57
2022 General $5,313 35
2021 General $2,616 15
2020 General $2,935 19
2019 General $7,291 70

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Yousef Odeh
  • Thoracic Surgery (Cardiothoracic Vascular Surgery) median
  • Middle half of Thoracic Surgery (Cardiothoracic Vascular Surgery)
  • National median

In program year 2025, general payments to Yousef Odeh were reported at $1,692. Among 4,073 Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles paid that year, the median was $791 and the middle half received between $208 and $3,074.

Show as a table
Year Yousef Odeh Thoracic Surgery (Cardiothoracic Vascular Surgery) median Middle half National median
2019 $7,291 $886 $178–$3,167 $163
2020 $2,935 $341 $108–$1,605 $114
2021 $2,616 $453 $125–$1,886 $132
2022 $5,313 $695 $180–$2,566 $149
2023 $2,234 $745 $205–$2,662 $160
2024 $3,333 $799 $214–$2,967 $164
2025 $1,692 $791 $208–$3,074 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Intuitive Surgical, Inc. $7,101 28 payments
  2. AstraZeneca Pharmaceuticals LP $4,163 8 payments
  3. Abiomed $3,348 31 payments
  4. Edwards Lifesciences Corporation $2,600 67 payments
  5. KLS-Martin L.P. $1,847 25 payments
  6. Medtronic, Inc. $1,778 55 payments
  7. Atricure, Inc. $1,695 42 payments
  8. Cook Incorporated $561 2 payments
  9. Biom'Up SA $372 4 payments
  10. Becton, Dickinson and Company $264 2 payments
  11. Other $1,684 38 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $15,672 290 payments
  2. Education $4,500 2 payments
  3. Consulting Fee $3,792 2 payments
  4. Travel and Lodging $1,448 8 payments
Products named General payments · program years 2019–2025
  1. Da Vinci Surgical System $4,101 27 payments
  2. TAGRISSO $4,012 5 payments
  3. Impella $3,109 28 payments
  4. DAVINCI XI $3,000 1 payment
  5. COREVALVE EVOLUT R $1,519 49 payments
  6. SYNERGY ABLATION SYSTEM $975 22 payments
  7. Edwards SAPIEN 3 Ultra Transcatheter Heart Valve $639 20 payments
  8. ATRICLIP LAA EXCLUSION SYSTEM $622 16 payments
  9. Cook Medical AAA $561 2 payments
  10. MITRIS RESILIA Mitral Valve $492 10 payments
  11. Other $5,501 105 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 4 drugs

Part D claims

101

Median for Cardiac Surgery: 68

Drug cost

$335

Median for Cardiac Surgery: $445

Branded share of claims

0%

Median for Cardiac Surgery: 15.7%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Atorvastatin Calcium Generic 37 $219
Metoprolol Tartrate Generic 28 $66
Potassium Chloride Generic 18 $33
Furosemide Generic 18 $17

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 411 Part D prescribers listed as Cardiac Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 43 billing codes

Paid by Medicare

$104,425

Medicare's payments for the services billed

Medicare patients

126

Average age 77

Services billed

344

51 women, 75 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 75%
Heart failure 53%
Diabetes 50%
Arthritis 46%
Atrial fibrillation 41%
Chronic kidney disease 40%
Depression 27%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

302 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Thoracic Surgery (Cardiothoracic Vascular Surgery) in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record